Inflammation

Showing NaN - NaN of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Heart Failure, Inflammation Trial in Dallas (Low Dose Colchicine, Placebo)

Not yet recruiting
  • Heart Failure
  • Inflammation
  • Low Dose Colchicine
  • Placebo
  • Dallas, Texas
    UT Southwestern Medical Center
Nov 11, 2023

Cardiovascular Risk, Chronic Kidney Disease, Inflammation Trial in Worldwide (Ziltivekimab, Placebo (ziltivekimab))

Recruiting
  • Cardiovascular Risk
  • +2 more
  • Birmingham, Alabama
  • +768 more
Dec 23, 2022

Chronic Kidney Diseases, Inflammation Trial in United States (Ziltivekimab)

Completed
  • Chronic Kidney Diseases
  • Inflammation
  • Ziltivekimab
  • Birmingham, Alabama
  • +48 more
Jul 6, 2021

Inflammation, Psoriasis Trial in United States (anti-IL-20, )

Terminated
  • Inflammation
  • Psoriasis
  • Birmingham, Alabama
  • +15 more
Feb 8, 2017

Inflammation, Systemic Lupus Erythematosus (SLE) Trial in United States (AGS-009, )

Completed
  • Inflammation
  • Systemic Lupus Erythematosus (SLE)
  • Birmingham, Alabama
  • +5 more
Jan 26, 2012